510(k) Report

510(k) · Cleared

Cleared

Kerasys Bioengineered Lamellar Patch Graft

K090078510(k) TraditionalCleared May 8, 2009116-day reviewClass II21 CFR 886.3130

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iop, Inc. · NXM Prosthesis, Eyelid Spacer/Graft, Biologic

Cleared on May 8, 2009 as substantially equivalent to K053622 (Iop, Inc., 2006) and 1 other predicate after a 116-day review. Its family tree reaches back 6 generations to 1992. 1 later device descends from it.

Decided
May 8, 2009
Review
116 days
Class
Class II
Product code
NXM
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K921895 (1992). 19 ancestors in all, the oldest K830889 (1983). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2002: 1 other ancestor2000: 4 other ancestors2001: 1 other ancestor1997: 3 other ancestors1992: 2 other ancestors1983: 1 other ancestor2023: 1 descendant clearedK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K034039 · Sis Plastic Surgery Matrix · Cook Biotech, Inc. · 2004K050246 · Sis Dermal Augmentation Strand · Cook Biotech, Inc. · 2005K053622 · Surgisis Ocular Graft · Iop, Inc. · 200619801990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 3 other ancestors3 generations back: 9 other ancestors4 generations back: 1 other ancestor 1 generation forward: 1 descendant K053622 · Surgisis Ocular Graft · Iop, Inc. · 2006K050246 · Sis Dermal Augmentation Strand · Cook Biotech, Inc. · 2005K034039 · Sis Plastic Surgery Matrix · Cook Biotech, Inc. · 2004K980431 · Surgisis · Cook Biotech, Inc. · 1998K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992−50
  1. Root · 6 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 5 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 4 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 3 generations backK034039 Sis Plastic Surgery MatrixCook Biotech, Inc. · 2004
  5. 2 generations backK050246 Sis Dermal Augmentation StrandCook Biotech, Inc. · 2005
  6. 1 generation backK053622 Surgisis Ocular GraftIop, Inc. · 2006
  7. This deviceK090078 Kerasys Bioengineered Lamellar Patch GraftIop, Inc. · 2009
  8. Descendant · cites it directly · 0 of its ownK223074 CorNeat EverPatchCorneat Vision, Ltd. · 2023 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K223074CorNeat EverPatchCorneat Vision, Ltd. · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−5K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−4K980431SurgisisCook Biotech, Inc.1998—
−3K034039Sis Plastic Surgery MatrixCook Biotech, Inc.2004—
−2K050246Sis Dermal Augmentation StrandCook Biotech, Inc.2005—
−1K053622Surgisis Ocular GraftIop, Inc.2006—
0 (this device)K090078Kerasys Bioengineered Lamellar Patch GraftIop, Inc.2009—
+1K223074CorNeat EverPatchCorneat Vision, Ltd.20233

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
199220
199730
200040
200110
200210
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
FIG. 1 — Lineage of K090078, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NXM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053622Surgisis Ocular Graft
Summary page 2
…Bioengineered Patch Name(s) tarSys Bioengineered Eyelid Graft lx1.5cm -prosthesis 510(k) K053622 K050246 Applied for 510(k) K090078 I…
Iop, Inc.2006—
*K050246Sis Dermal Augmentation Strand
Summary page 2
…tarSys Bioengineered Eyelid Graft lx1.5cm -prosthesis 510(k) K053622 K050246 Applied for 510(k) K090078 I 11…
Cook Biotech, Inc.2005—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223074CorNeat EverPatchCorneat Vision, Ltd.20230

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 3.1 years on median.
  • 1 of the 19 ancestors has a recall of any class.
  • Of its descendants, K223074 (Corneat Vision, Ltd., 2023) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NXM devices

NXM Prosthesis, Eyelid Spacer/Graft, Biologic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · NXM

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NXM

Too few NXM 510(k)s in any year since 2007 to give a median.

Recalls per year · NXM

No recall names NXM since 2007.

Adverse event reports per year · NXM

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code NXM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—01
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The KaraSys Bioengineered Lamellar Patch Graft is intended for implantation to reinforce sclera and aid the physical reconstruction of the ocular surface. KaraSys is labeled for single use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090078: Kerasys Bioengineered Lamellar Patch Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K090078

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026